Showing results (71-80 of 136) with videos related to
Sort By:
Pageof 14
Mayo Clinic Proceedings|August 11, 2004
Impact of FUTON and NAA bias on visibility of researchNarayana S Murali, Hema R Murali, Paranee Auethavekiat, et al.The Journal of the Association of Physicians of India|December 14, 2025
Reimagining Type 1 Diabetes Care in India: A Three-decade Reflection on Challenges, Innovations, and Opportunities since the Diabetes Control and Complications TrialBanshi Saboo, Shambo S Samajdar, Rishi Shukla, et al.The Lancet Regional Health. Southeast Asia|July 5, 2022
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialMonika Tandon, Wen Wu, Keith Moore, et al.Journal of Diabetes Science and Technology|May 31, 2014
A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)Vikas Pai, A Paneerselvam, Satinath Mukhopadhyay, et al.Advances in Therapy|June 7, 2025
An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to PractitionersJothydev Kesavadev, Anjana Basanth, Arun Shankar, et al.Journal of the Indian Medical Association|October 25, 2003
Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcerShashank Joshi, Suresh Maroli, N D Moulick, et al.Advances in Therapy|November 20, 2016
Unproven Therapies for Diabetes and Their ImplicationsJothydev Kesavadev, Banshi Saboo, Shaukat Sadikot, et al.Expert Opinion on Pharmacotherapy|November 10, 2022
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 studyHarold E Lebovitz, Alexander Fleming, Alan D Cherrington, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 27, 2023
Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian PerspectiveViswanathan Mohan, Shashank Joshi, Ambrish Mithal, et al.The Lancet Regional Health. Southeast Asia|November 14, 2022
Correction to "SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial"Monika Tandon, Wen Wu, Keith Moore, et al.Pageof 14